| 1. 24) Ting Sun＃, Yongzhi Wang＃, Xing Liu, Zhaohui Li, Jie Zhang, Jianhua Yang, Jing Lu, Liying Qu, Yunyun Duan, Zhizheng zhuo, Dan Cheng, Xiaolu Xu, Wenqing Jia*, Yaou Liu*.Deep learning based on preoperative MR images improves the predictive power of survival models in spinal cord astrocytomas.Neuro Oncol.2023.12.DOI：10.1093/neuonc/noac280.SCI |
| 2. 7） Rui-Chao Chai#*, Hao Yan#, Song-Yuan An, Bo Pang, Hui-Yuan Chen, Quan-Hua Mu, Ke-Nan Zhang, Yao-Wu Zhang, Yu-Qing Liu, Xing Liu, Zheng Zhao, Tao Jiang, Yong-Zhi Wang*, Wen-Qing Jia*.Genomic profiling and prognostic factors of H3 K27M-mutant spinal cord diffuse glioma.Brain Pathology.2023.2.e13153.SCI |
| 3. Zhang Q＃, Cheng S＃, Wang Y＃,Wang M＃, Lu Y, Wen Z, Ge Y, Ma Q, Chen Y, Zhang Y, Cao R, Li M, Liu W, Wang B, Wu Q*,Jia W*, Wang X*.Interrogation of the microenvironmental landscape in spinal ependymomas reveals dual functions of tumor-associated macrophages.Nature Communications.2021.12.6867.SCI |
| 4. Chai R#, Li G#, Liu Y, Zhang K, Zhao Z, Wu F, Chang Y，Pang B，Li J，Li Y，Jiang T*，Wang Y*.Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma.Cancer Biology & Medicine.2021.18.271-282.SCI |
| 5. Rui-Chao Chai#*, Yu-Zhou Chang#, Xin Chang, Bo Pang, Song Yuan An, Ke-Nan Zhang, Yuan-Hao Chang, Tao Jiang*, Yong-Zhi Wang*.YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m6A modification to activate NF-κB and promote the malignant progression of glioma.J Hematol Oncol.2021.14(1).109.SCI |
| 6. Yu-Zhou Chang#, Rui-Chao Chai#*, Bo Pang#, Xin Chang, Song-Yuan An, Ke-Nan Zhang, Tao Jiang, Yong-Zhi Wang*.METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.Cancer Letters.2021.511.36-46.SCI |
| 7. Bo Pang#，Rui-Chao Chai#*，Yao-Wu Zhang，Yu-Zhou Chang，Wei-Hao Liu, Wen-Qing Jia*, Yong-Zhi Wang*.A comprehensive model including preoperative peripheral blood inflammatory markers for prediction of the prognosis of diffuse spinal cord astrocytoma following surgery.European Spine Journal.2021.25.1-10.SCI |
| 8. Chang YZ#, Li GZ, Pang B, Zhang KN, Zhang XH, Wang YZ*, Jiang ZL*, Chai RC*.Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas.Front Cell Dev Biol.2020.8.580464.SCI |
| 9. Rui-Chao Chai#, Yao-Wu Zhang#, Yu-Qing Liu, Yu-Zhou Chang, Bo Pang, Tao Jiang, Wen-Qing Jia*, Yong-Zhi Wang*. .The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation. Acta Neuropathologica Communications.Acta Neuropathologica Communications.2020.8（1）.40.SCI |
| 10. Zhang YW#, Chai RC#, Cao R, Jiang WJ, Liu WH, Xu YL, Yang J, Wang YZ*, Jia WQ*.Clinicopathological characteristics and survival of spinal cord astrocytomas.Cancer Med.2020.9（19）.6996-7006.SCI |
| 11. Rui-Chao Chai#, Yi-Ming Li#, Ke-Nan Zhang, Yu-Qing Liu, Zheng Zhao,Yu-Zhou Chang, Yuan-Hao Chang, Guan-Zhang Li, Kuan-Yu Wang, Fan Wu*, Yong-Zhi Wang*.RNA processing genes characterize RNA splicing and further stratify lower-grade glioma.JCI Insight.2019.4(17).e130591.SCI |
| 12. Rui-Chao Chai#, Ke-Nan Zhang#, Yu-Qing Liu, Fan Wu, Zheng Zhao, Kuan-Yu Wang, Tao Jiang, Yong-Zhi Wang*.Combinations of four or more CpGs methylation present equivalent predictive value for MGMT expression and temozolomide therapeutic prognosis in gliomas.CNS Neurosci Ther.2019.25（3）.314-322.SCI |
| 13. Chai RC#, Wu F#, Wang QX#, Zhang S, Zhang KN, Liu YQ, Zhao Z, Jiang T, Wang YZ*, Kang CS*.m6A RNA methylation regulators contribute to malignant progression and have clinical prognostic impact in gliomas.Aging.2019.11(4).1204-1225.SCI |
| 14. Rui-Chao Chai#, Yu-Zhou Chang#, Ke-Nan Zhang, Jing-Jun Li, Hua Huang, Fan, Wu*, Yu-Qing Liu*, Yong-Zhi Wang*.A novel DNA methylation-based signature can predict the responses of MGMT promoter unmethylated glioblastomas to temozolomide.Frontiers in Genetics.2019.10（9）.10.3389/fgene.2019.00910.SCI |
| 15. Rui-Chao Chai#, Yu-Qing Liu#, Ke-Nan Zhang#, Fan Wu, Zheng Zhao, Kuan-Yu Wang, Tao Jiang, Yong-Zhi Wang*.A novel analytical model of MGMT methylation pyrosequencing offers improved predictive performance in patients with gliomas.Modern Pathology.2019.32（1）.4-15.SCI |
| 16. Rui-Chao Chai#, Ke-Nan Zhang, Yu-Zhou Chang, Fan Wu, Yu-Qing Liu, Zheng Zhao, Kuan-Yu Wang, Yuan-Hao Chang, Tao Jiang*，Yong-Zhi Wang*.Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.Carcinogenesis.2019.6（3）.10.1093/carcin/bgz102.SCI |
| 17. 王永志＃，柴睿超，刘玉清，刘幸，姚坤，曾凡，张忠*.基于整合诊断模式解析胶质母细胞瘤含少突胶质细胞瘤成分.中华神经外科杂志.2018.34（7）.737-740.核心期刊 |
| 18. 柴睿超＃,刘玉清,吴凡,曾凡,王军梅,江涛,王永志*.焦磷酸测序定量检测脑胶质瘤IDH1 132H突变.中华神经外科杂志.2018.34（7）.732-736.核心期刊 |
| 19. Wang Y＃, Lin Z＃, Li Z, Zhao M, Hu M, Zhang H, Chen X, Jiang Z*.Tumor Location and Survival Outcomes in Adult Patients with Supratentorial Glioblastoma by Levels of Toll-like Receptor 9 Expression.World Neurosurg.2017.97.279-283.SCI |
| 20. Li MY＃, Yang P, Liu YW, Zhang CB, Wang KY, Wang YY, Yao K, Zhang W, Qiu XG, Li WB, Peng XX, Wang YZ*, Jiang T*.Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas.Sci Rep.2016.6.21141.SCI |
| 21. Wang Y＃, Lin Z＃, Li Z, Zhao M, Hu M, Zhang H, Chen X, Jiang Z*.The incidence and risk factors of postoperative entrapped temporal horn in trigone meningiomas.World Neurosurg.2016.90.511-517.SCI |
| 22. 王永志＃, 陈宝师，张忠*.神经外科亚专业化模式下研究生培养模式的思考.中国医药导报.2016.13(28).120-122.核心期刊 |
| 23. 张忠＃，王永志*，季玉陈，陈宝师.幕下菊形团形成型胶质神经元肿瘤.中国微侵袭神经外科杂志.2015.20(7).293-295.核心期刊 |
| 24. Wang H＃, Wang Y＃, Bao Z, Zhang C, Liu Y, Cai J, Jiang C*.Hypomethylated Rab27b is a progression-associated prognostic biomarker of glioma regulating MMP-9 to promote invasion.Oncol Rep.2015.34.1503-1509.SCI |
| 25. 29) 王永志＃，江涛*.神经外科研究生临床研究能力培养的思考与实践.新乡医学院学报.2015.32(4）.378-380.核心期刊 |
| 26. 王永志＃，杨帆，季玉陈，刘彦伟，游赣，张伟，江涛*.手术切除程度对胶质母细胞瘤预后预测因素的影响.中国微侵袭神经外科杂志.2015.20(7).289-292.核心期刊 |
| 27. Wang Y＃, Li S＃, Chen L, You G, Bao Z, Yan W, Shi Z, Chen Y, Yao K, Kang C*, Jiang T*.Glioblastoma with oligodendroglioma component: distinct clinical behavior, genetic alterations and outcome.Neuro Oncol.2012.14(4).518-525.SCI |
